Renal Business Today

Vascular Access

Grafts Grown from Tissue of Dialysis Patients

PARIS—Dialysis patients have been successfully fitted with blood vessels engineered solely from their own living tissue, according to a study published in The Lancet. ...More
April 29, 2009
Posted in News, Business, Clinical & Pharma, Practice Management
Educated Dialysis Patients More Likely to Get Fistulas

WASHINGTON—Kidney disease patients who are educated about dialysis are more likely to get permanent vascular access than less knowledgeable patients, according to a study published online April 23 in the Clinical Journal of the American Society Nephrology. ...More
April 23, 2009
Posted in News, Clinical & Pharma, Practice Management
CMS Not Enacting Vascular Access Code Changes

WASHINGTON—The Centers for Medicare & Medicaid Services have not enacted coding edits that would have changed how certain vascular access procedures are billed. ...More
April 10, 2009
Posted in News, Business, Clinical & Pharma
Former Lufkin DaVita Nurse Makes Bail

LUFKIN, Texas—A former DaVita Lufkin nurse charged with allegedly injecting bleach into dialysis patients bloodlines, killing five, has posted a $500,000 bond and has been released from jail, according to a report from the Lufkin Daily News. ...More
April 9, 2009
Posted in News, Clinical & Pharma
AV Fistulas Remain Gold Standard for Dialysis Patients

SAN DIEGO—A new study shows that for those individuals with chronic kidney disease (CKD), arteriovenous (AV) fistulas remain the gold standard for maintaining access to one's circulatory system to provide dialysis no matter a person’s age.Interventional ...More
March 9, 2009
Posted in News, Business, Clinical & Pharma, Practice Management
RBT Roundtable: Vascular Access

Vascular access is an essential component of a kidney disease patient’s dialysis care. It literally connects patients to the dialysis machine to clean their blood. It can also pose a problem for patients’ health with infection, which, in turn, can be costly for the ...More
January 30, 2009
Posted in Articles, Business, Clinical & Pharma
Lifeline Vascular Treats Quarter Millionth Patient

VERNON HILLS, Ill.—Lifeline Vascular Access announced its network of managed vascular access centers has collectively ‘touched’ 250,000 patients. ...More
January 29, 2009
Posted in News, Business, Clinical & Pharma
Ark Therapeutics Completes Trinam Potency Test Qualification

LONDON—Ark Therapeutics Group plc successfully completed the work requested by the U.S. Food and Drug Administration (FDA) to qualify a potency test for Trinam®. ...More
January 13, 2009
Posted in News, Clinical & Pharma, Government & Regulation
FDA approves Bard’s endovascular stent graft

MURRAY HILL, N.J.—C.R. Bard can begin marketing its Flair Endovascular Stent Graft after receiving approval from the U.S. Food and Drug Administration. ...More
October 29, 2008
Posted in News, Business, Government & Regulation
Pervasis hires former Genzyme exec to be CEO

CAMBRIDGE, Mass.—Biotech company Pervasis Therapeutics has hired former Genzyme executive Frederic Chereau to become the company’s new chief executive officer ...More
October 22, 2008
Posted in News, Business, Clinical & Pharma